“National Guard Health”, “Kimark” and “Casao” review the Kingdom’s leadership in biotechnology during the Bio USA 2025 conference

Health affairs of the Ministry of National Guard, King Abdullah International Medical Research Center “Kimark”, King Saud bin Abdulaziz University for Health Sciences “Kasao” are participating in the Saudi pavilion at the International Convender 2025 conference, the world’s largest event in the field of biotechnology, which is held this year in Boston, USA. The Kingdom is on the global scene as an emerging and influential center in the field of biotechnology, in line with the targets of the Kingdom’s 2030 vision and the National Biotechnology Strategy.

During the participation, “Kimark” reviews a set of national achievements and leading initiatives that include the largest national network of clinical experiences that include more than (100) existing experiences and (11,000) registered patients, the first unit of the first stage of clinical trials in the Kingdom, the Saudi biological bank associated with clinical data and a multi -ryx research network, pioneering programs for cell therapy and genes, and the secret cord blood record, and the secret cord blood record, Induced stem cells, international partnerships with leading universities and companies to translate innovations into realistic therapeutic applications, and the Saudi pavilion provides a space for holding bilateral meetings with the aim of building partnerships with global biotechnology companies, and exploring cooperation opportunities in research, development and biological manufacturing.

The Saudi pavilion will witness the presentation of five pivotal sessions within the “Shedding Speaker” and “General Session”, most notably the SUPER Session entitled “Partnership for Progress … Explore Innovation and Opportunities in Biotechnology in the Kingdom of Saudi Arabia”, in which His Excellency Professor Dr. Bandar bin Abdul Mohsen Al -Qenawi participates in addition to a group of leaders in the areas of health, investment and scientific research.

“Kimark” will present qualitative offers within corporate sessions that include enhancing innovation in biotechnology through health sciences and research, the Saudi biological bank and 2030 vision, the Kingdom’s strategic vision in the field of biotechnology.

In addition to the scientific sessions, the Ministry of Health launches through its official participation a speeding program dedicated to startups in biotechnology, in addition to organizing a high -level reception that brings together a group of investors, experts and corporate leaders from different countries of the world, to enhance dialogue and discuss cooperation opportunities with the Kingdom.

This participation reflects the serious commitment of the Kingdom to build an integrated environment for research and development, supported by an advanced digital structure, a flexible regulatory framework, and national institutional and international institutional partnerships, and “Kimark” and Casaw, through this participation, seeks to enable the transfer of knowledge, localize vital industries, and enhance the Kingdom’s position as a global axis in life sciences and biotechnology.

The Kingdom receives its visitors in the Saudi pavilion during the exhibition period in the platform No. (3265) at the Boston Conference and Exhibition Center, to see its programs and initiatives in the fields of biotechnology, quality of life, and industrial resettlement.